CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863158720
- Phone
- (646) 427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-23 | Lazar David E. Director | Sale · Series AA Convertible Non-Redeemable Preferred Stock | −196,800 | 103,200 | ||
| 2026-03-23 | Lazar David E. Director | Sale · Series AAA Convertible Non-Redeemable Preferred Stock | −700,000 | 0 | ||
| 2026-02-26 | Jabbour Jerome D Director | Grant or award · Option to Buy Common Stock | +25,000 | 25,000 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Returned to the company · Warrants (right to buy) | −3,033 | 0 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Grant or award · Warrants (right to buy) | +3,033 | 3,033 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Returned to the company · Warrants (right to buy) | −1,519 | 0 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Grant or award · Warrants (right to buy) | +1,519 | 1,519 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Returned to the company · Warrants (right to buy) | −12,136 | 0 | ||
| 2026-02-11 | Meckler Jeffrey A Co-Chief Executive Officer | Grant or award · Warrants (right to buy) | +12,136 | 12,136 | ||
| 2026-01-20 | Ben-Tzvi Avraham Director | Grant or award | +25,000 | 25,100 | ||
| 2026-01-07 | NATAN DAVID Director | Grant or award · Option to Buy Common Stock | +25,000 | 25,000 | ||
| 2025-12-23 | Ben-Tzvi Avraham Director | Grant or award · Option to Buy Common Stock | +25,000 | 25,000 | ||
| 2025-12-22 | Sassi Nir Chief Financial Officer | Grant or award | +26,758 | $2.03 | $54K | 26,758 |
| 2025-12-22 | Meckler Jeffrey A Co-Chief Executive Officer | Grant or award | +216,617 | $2.03 | $440K | 229,929 |
| 2025-12-22 | Newman Michael James CSO and Director | Grant or award | +52,204 | $2.03 | $106K | 101,074 |
| 2025-12-22 | Linscott Walt Addison Chief Operating Officer | Grant or award | +54,421 | $2.03 | $110K | 54,426 |
| 2025-07-27 | Meckler Jeffrey A Chief Executive Officer | Grant or award | +6,068 | $8.30 | $50K | 13,312 |
| 2025-07-27 | Meckler Jeffrey A Chief Executive Officer | Grant or award · Common Stock Warrants | +12,136 | $8.30 | $101K | 16,688 |
| 2025-06-10 | Pomerantz Roger Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-10 | Martell Robert Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 |
Page 1 of 7 · 127 trades